Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management.
von Possel R, Menge B, Deschermeier C, Fritzsche C, Hemmer C, Geerdes-Fenge H, Loebermann M, Schulz A, Lattwein E, Steinhagen K, Tönnies R, Ahrendt R, Emmerich P. von Possel R, et al. Among authors: fritzsche c. Viruses. 2024 Jan 6;16(1):91. doi: 10.3390/v16010091. Viruses. 2024. PMID: 38257792 Free PMC article.
Bilateral upper arm swelling and weight loss.
Fritzsche C, Loebermann M, Reisinger EC. Fritzsche C, et al. Gastroenterology. 2011 Nov;141(5):1564, 1950-1. doi: 10.1053/j.gastro.2010.09.011. Epub 2011 Sep 28. Gastroenterology. 2011. PMID: 21963796 No abstract available.
A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults.
Loebermann M, Fritzsche C, Geerdes-Fenge H, Heijnen E, Kirby D, Reisinger EC. Loebermann M, et al. Among authors: fritzsche c. Infection. 2019 Feb;47(1):105-109. doi: 10.1007/s15010-018-1233-2. Epub 2018 Oct 8. Infection. 2019. PMID: 30298473 Clinical Trial.
Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
Loebermann M, Voss U, Meyer S, Bosse D, Fritzsche C, Klammt S, Frimmel S, Riebold D, Reisinger EC. Loebermann M, et al. Among authors: fritzsche c. PLoS One. 2013 Aug 16;8(8):e70866. doi: 10.1371/journal.pone.0070866. eCollection 2013. PLoS One. 2013. PMID: 23976960 Free PMC article. Clinical Trial.
69 results